Molecular Devices Announces Webcast of Presentation at UBS Global Life Sciences Conference
22 September 2004 - 9:14AM
PR Newswire (US)
Molecular Devices Announces Webcast of Presentation at UBS Global
Life Sciences Conference SUNNYVALE, Calif., Sept. 21
/PRNewswire-FirstCall/ -- Molecular Devices Corporation
(NASDAQ:MDCC), a leader in innovative solutions for drug discovery
and life sciences research, today announced that Joseph D. Keegan,
Ph.D., CEO and President, will present at the UBS Global Life
Sciences Conference, Wednesday, September 29, 2004 at 12:00 noon
(Eastern), at the Grand Hyatt New York. Molecular Devices' audio
presentation will be webcast live, and can be accessed at:
http://www.ibb.ubs.com/ or on the investor page at the Company's
website http://www.moleculardevices.com/. The audio presentation
will be archived on the Company's website for 5 days. Molecular
Devices Corporation is a leading developer of high-performance,
bioanalytical measurement systems that accelerate and improve drug
discovery and other life sciences research. Molecular Devices'
systems and consumables enable pharmaceutical and biotechnology
companies to leverage advances in genomics and combinatorial
chemistry by facilitating the high-throughput and cost-effective
identification and evaluation of drug technologies that integrate
its expertise in engineering, molecular and cell biology, and
chemistry. Molecular Devices enables its customers to improve
research productivity and effectiveness, which ultimately
accelerates the complex process of discovering and developing new
drugs. DATASOURCE: Molecular Devices Corporation CONTACT: Tim
Harkness of Molecular Devices Corporation, +1-408-747-3533 Web
site: http://www.moleculardevices.com/
Copyright
Molecular Devices (NASDAQ:MDCC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Molecular Devices (NASDAQ:MDCC)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Molecular Devices (MM) (NASDAQ): 0 recent articles
More Molecular Devices (MM) News Articles